Recommended primary outcomes for clinical trials evaluating hemostatic blood products and agents in patients with bleeding: Proceedings of a National Heart Lung and Blood Institute and US Department of Defense Consensus Conference.
Spinella PC, El Kassar N, Cap AP, Kindzelski AL, Almond CS, Barkun A, Gernsheimer TB, Goldstein JN, Holcomb JB, Iorio A, Jensen DM, Key NS, Levy JH, Mayer SA, Moore EE, Stanworth SJ, Lewis RJ, Steiner ME; Hemostasis Trials Outcomes Working Group.
Spinella PC, et al. Among authors: key ns.
J Trauma Acute Care Surg. 2021 Aug 1;91(2S Suppl 2):S19-S25. doi: 10.1097/TA.0000000000003300.
J Trauma Acute Care Surg. 2021.
PMID: 34039915
Free PMC article.